hsa_circ_0035483

ncRNA information

ncRNA name

hsa_circ_0035483

Specific or universal ncRNAs

Specific ncRNAs

Class

Circular RNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

hsa-miR-335

Cancer information

Cancer name

Renal Cancer

Cancer site

Kidney

Treatment information

Treatment type

Chemotherapy

Drug

Gemcitabine

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Hsa_circ_0035483 promotes autophagy and tumor growth and enhances gemcitabine resistance in RCC by regulating hsa-miR-335/CCNB1, and silenced hsa_circ_0035483 can enhance gemcitabine sensitivity in vivo.

Tissue resource

kidney cancer tissues and adjacent normal tissues

Experiment

PCR,Western blot,Luciferase reporter assay


Institute

the First Affiliated Hospital of Zhengzhou University

Country

China

Continent

Asia